The worldwide sector for Active Pharmaceutical Ingredient (API) suppliers is a complex landscape, spanning numerous regions . The People’s Republic of China currently holds the manufacturing of APIs, trailing India, which is a key player in both generic API supply . European businesses, particularly in nations like Germany, Switzerland, and Italy